IE37186L - Benzylpyrimidines - Google Patents

Benzylpyrimidines

Info

Publication number
IE37186L
IE37186L IE721597A IE159772A IE37186L IE 37186 L IE37186 L IE 37186L IE 721597 A IE721597 A IE 721597A IE 159772 A IE159772 A IE 159772A IE 37186 L IE37186 L IE 37186L
Authority
IE
Ireland
Prior art keywords
dec
alkoxy
benzylpyrimidines
antibacterial
gb1406307a
Prior art date
Application number
IE721597A
Other versions
IE37186B1 (en
Original Assignee
Plantex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL38276A external-priority patent/IL38276A/en
Priority claimed from IL38412A external-priority patent/IL38412A/en
Application filed by Plantex Ltd filed Critical Plantex Ltd
Publication of IE37186L publication Critical patent/IE37186L/en
Publication of IE37186B1 publication Critical patent/IE37186B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1406307 Antibacterial medicines PLANTEX LTD 1 Dec 1972 [1 Dec 1971 20 Dec 1971] 55597/72 Heading A5B [Also in Division C2] Pharmaceutical compositions in conventional forms for oral administration and having antibacterial activity comprise a compound of formula I wherein R 1 and R 2 are each H, halogen, C 1-5 alkyl or C 1-5 alkoxy and R 3 and R 4 are each C 1-5 alkoxy and a carrier or diluent and optionally a sulphonamide e.g. a sulphamethoxazole or a sulphaquinoxaline. [GB1406307A]
IE1597/72A 1971-12-01 1972-11-20 Improvements in and relating to the production of benzyl-pyrimidines IE37186B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL38276A IL38276A (en) 1971-12-01 1971-12-01 Process for the preparation of 2,4-diamino-5-substituted benzylpyrimidines
IL38412A IL38412A (en) 1971-12-20 1971-12-20 Alpha-cyano-3,4,5-trialkoxycinnamic acid derivatives

Publications (2)

Publication Number Publication Date
IE37186L true IE37186L (en) 1973-06-01
IE37186B1 IE37186B1 (en) 1977-05-25

Family

ID=26320466

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1597/72A IE37186B1 (en) 1971-12-01 1972-11-20 Improvements in and relating to the production of benzyl-pyrimidines

Country Status (9)

Country Link
BE (1) BE792122A (en)
DK (1) DK132703C (en)
GB (1) GB1406307A (en)
HK (1) HK45676A (en)
IE (1) IE37186B1 (en)
KE (1) KE2660A (en)
NO (1) NO136195C (en)
OA (1) OA04279A (en)
SE (2) SE407061B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202341A (en) * 1987-03-11 1993-04-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds having tyrosine kinase inhibiting activity
DE3874257T2 (en) * 1987-03-11 1993-02-11 Kanegafuchi Chemical Ind HYDROXYSTYRENE DERIVATIVES.
US5089516A (en) * 1987-03-11 1992-02-18 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity

Also Published As

Publication number Publication date
OA04279A (en) 1979-12-31
KE2660A (en) 1976-10-01
IE37186B1 (en) 1977-05-25
BE792122A (en) 1973-05-30
SE407061B (en) 1979-03-12
DK132703C (en) 1976-06-21
NO136195B (en) 1977-04-25
GB1406307A (en) 1975-09-17
DK132703B (en) 1976-01-26
HK45676A (en) 1976-07-23
SE7513881L (en) 1975-12-09
NO136195C (en) 1977-08-03

Similar Documents

Publication Publication Date Title
GB1454778A (en) Therapeutic compositions comprising dioxamates
IE38012B1 (en) Benzothiadiazoles
AU465934B2 (en) Preparation of d,d'-2,2'-(ethylenedimino) -di-1-butanol hydrochloride
GB1290818A (en)
GB1461032A (en) Erthromycylamine derivatives
GB1458251A (en) 1-phenyl-2-amino-ethanol derivatives
GB1439724A (en) Berbine derivatives and pharmaceutical compositions containing them
GB1389128A (en) Benzoxazine derivatives their preparation and use
IE37186B1 (en) Improvements in and relating to the production of benzyl-pyrimidines
IE33371B1 (en) Protozoacidally-active substituted guanidines
GB1394619A (en) Imides
IE36598B1 (en) Phthalazone derivatives
GB1263116A (en) Chloramphenicol and thiamphenicol derivatives
IE37932L (en) Xylidides
GB1374396A (en) Thymol derivatives
GB1416281A (en) N-benzene-sulphonyl-erythromycylamine derivatives
IE31965L (en) Quinoxaline derivatives
IE39926L (en) Compositions containing indanyloxyalkanoic acid compounds
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
GB1164058A (en) Novel Sulphanilamides and a process for the manufacture thereof
IE34826B1 (en) New derivatives of neriifolin
GB1357733A (en) 1,2,4-oxadiazole derivatives
GB1172696A (en) Phenyl-Indandione Derivatives
GB1313274A (en) Bicycloalkanecarboxymides and the preparation thereof
GB1160448A (en) Alkanolamine Derivatives